Skip to main content

Caliper Collects $32.5M from Aclara on 2001 Settlement

SAN FRANCISCO, Oct. 15 - Caliper Technologies said today it received $32.5 million from Aclara Biosciences as part of a settlement from 2001 litigation.

 

Caliper will recognize $5 million of the payment as licensee fee revenue and $27.5 million as part of the settlement in its income statement, the company said.

 

Caliper said it will also receive a minimum of $2.5 million as royalty payments by December 31 of 2002 and 2003 under terms of the settlement.

 

In 2001, Caliper and Aclara settled lawsuits brought upon Aclara for infringing on lab-on-chip technology and Caliper for infringing on microfluidics methods. Previously, a jury granted Caliper $52 million in damages against Aclara for misappropriating its trade secrets, though this amount was reduced by a judge to $35 million.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.